Skip to main content
. 2016 Jun 20;9:76–81. doi: 10.1007/s12254-016-0268-2

Fig. 3.

Fig. 3

Progression-free survival (PFS) in the PALOMA-1 phase II trial comparing palbociclib plus letrozole with letrozole alone in the first-line setting [4]. HR = Hazard Ratio, CI = Confidence interval, PFS = Progression-free surivival